Los Angeles Capital Management LLC Editas Medicine, Inc. Transaction History

Los Angeles Capital Management LLC

$24.2 Billion
Q4 2024

A detailed history of Los Angeles Capital Management LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 98,839 shares of EDIT stock, worth $189,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,839

Previous 117,639 15.98%

Holding current value

$189,770

Previous $401,000 68.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$1.2 - $3.76 $22,560 - $70,688	-18,800 Reduced 15.98%	98,839 $125,000
Q3 2024 Nov 04, 2024	SELL	$3.39 - $5.96 $45,120 - $79,327	-13,310 Reduced 10.16%	117,639 $401,000
Q2 2024 Aug 05, 2024	SELL	$4.67 - $7.28 $79,081 - $123,279	-16,934 Reduced 11.45%	130,949 $611,000
Q1 2024 Apr 05, 2024	BUY	$7.03 - $11.07 $1.04 Million - $1.64 Million	147,883 New	147,883 $1.1 Million
Q3 2022 Nov 02, 2022	BUY	$12.16 - $19.42 $4,705 - $7,515	387 Added 1.07%	36,453 $446,000
Q2 2022 Aug 05, 2022	BUY	$9.99 - $21.35 $41,728 - $89,178	4,177 Added 13.1%	36,066 $427,000
Q1 2022 May 06, 2022	BUY	$14.08 - $27.63 $221,689 - $435,034	15,745 Added 97.53%	31,889 $607,000
Q4 2021 Feb 03, 2022	SELL	$26.55 - $40.57 $4,433 - $6,775	-167 Reduced 1.02%	16,144 $429,000
Q2 2021 Aug 05, 2021	SELL	$31.29 - $56.64 $123,282 - $223,161	-3,940 Reduced 19.46%	16,311 $924,000
Q1 2021 May 05, 2021	SELL	$39.71 - $90.58 $738,645 - $1.68 Million	-18,601 Reduced 47.88%	20,251 $850,000
Q4 2020 Feb 04, 2021	SELL	$27.07 - $84.35 $183,805 - $572,736	-6,790 Reduced 14.88%	38,852 $2.72 Million
Q3 2020 Nov 02, 2020	SELL	$28.06 - $37.16 $389,753 - $516,152	-13,890 Reduced 23.33%	45,642 $1.28 Million
Q2 2020 Aug 05, 2020	SELL	$18.5 - $34.34 $56,795 - $105,423	-3,070 Reduced 4.9%	59,532 $1.76 Million
Q1 2020 May 04, 2020	BUY	$14.88 - $32.78 $61,082 - $134,561	4,105 Added 7.02%	62,602 $1.24 Million
Q4 2019 Feb 07, 2020	BUY	$19.49 - $32.63 $1.14 Million - $1.91 Million	58,497 New	58,497 $1.73 Million
Q3 2019 Nov 07, 2019	SELL	$22.49 - $26.81 $285,735 - $340,621	-12,705 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$20.48 - $27.76 $106,905 - $144,907	-5,220 Reduced 29.12%	12,705 $314,000
Q1 2019 Apr 25, 2019	BUY	$19.43 - $26.41 $348,282 - $473,399	17,925 New	17,925 $438,000

Others Institutions Holding EDIT

# of Institutions

225

Shares Held

54.2M

Call Options Held

412K

Put Options Held

355K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $132M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Editas Medicine, Inc. Transaction History